Correlation Between Mangalam Drugs and Metropolis Healthcare

Can any of the company-specific risk be diversified away by investing in both Mangalam Drugs and Metropolis Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangalam Drugs and Metropolis Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mangalam Drugs And and Metropolis Healthcare Limited, you can compare the effects of market volatilities on Mangalam Drugs and Metropolis Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangalam Drugs with a short position of Metropolis Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangalam Drugs and Metropolis Healthcare.

Diversification Opportunities for Mangalam Drugs and Metropolis Healthcare

0.52

Correlation Coefficient

Mangalam Drugs  Metropolis Healthcare

Very weak diversification

The 3 months correlation between Mangalam and Metropolis is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Mangalam Drugs And and Metropolis Healthcare Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Metropolis Healthcare and Mangalam Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangalam Drugs And are associated (or correlated) with Metropolis Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Metropolis Healthcare has no effect on the direction of Mangalam Drugs i.e., Mangalam Drugs and Metropolis Healthcare go up and down completely randomly.

Pair Corralation between Mangalam Drugs and Metropolis Healthcare

Assuming the 90 days trading horizon Mangalam Drugs is expected to generate 3.15 times less return on investment than Metropolis Healthcare. In addition to that, Mangalam Drugs is 1.37 times more volatile than Metropolis Healthcare Limited. It trades about 0.01 of its total potential returns per unit of risk. Metropolis Healthcare Limited is currently generating about 0.06 per unit of volatility. If you would invest  130,147  in Metropolis Healthcare Limited on October 5, 2024 and sell it today you would earn a total of  74,758  from holding Metropolis Healthcare Limited or generate 57.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.79%
Values	Daily Returns

Mangalam Drugs And  vs.  Metropolis Healthcare Limited

Mangalam Drugs And

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Mangalam Drugs And are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong essential indicators, Mangalam Drugs is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Metropolis Healthcare

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Metropolis Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Metropolis Healthcare is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Mangalam Drugs and Metropolis Healthcare

The main advantage of trading using opposite Mangalam Drugs and Metropolis Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangalam Drugs position performs unexpectedly, Metropolis Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Metropolis Healthcare will offset losses from the drop in Metropolis Healthcare's long position.

The idea behind Mangalam Drugs And and Metropolis Healthcare Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .